NCT07133568 (FEXO-COM) is a NA clinical trial of Fun Exercise for Older Adults (FEXO) in Sarcopenia, sponsored by Cardenal Herrera University.

Who is sponsoring NCT07133568?

NCT07133568 is sponsored by Cardenal Herrera University.

What drugs are being tested in NCT07133568?

Interventions in NCT07133568: Fun Exercise for Older Adults (FEXO), OTAGO.

What condition does NCT07133568 study?

NCT07133568 studies Sarcopenia, Frailty Syndrome.

Is NCT07133568 still recruiting?

NCT07133568 is currently completed. Last updated 8 April 2026.

Last reviewed 2026-04-08 · How we verify

NCT07133568: FEXO-COM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fun Exercise Intervention for Older Adults to Improve Intrinsic Capacity and Motivation

Completed NA Last updated 8 April 2026

What this trial tests

NA trial testing Fun Exercise for Older Adults (FEXO) in Sarcopenia in 120 participants. Completed in 31 December 2025.

Timeline

4 September 2025

Primary endpoint
19 December 2025

31 December 2025

Quick facts

Lead sponsor	Cardenal Herrera University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	120
Start date	4 September 2025
Primary completion	19 December 2025
Estimated completion	31 December 2025
Sites	1 location across Spain

Drugs / interventions tested

Fun Exercise for Older Adults (FEXO)
OTAGO

Conditions studied

Sarcopenia — all drugs for Sarcopenia →
Frailty Syndrome — all drugs for Frailty Syndrome →

Sponsor

Cardenal Herrera University

Who can join

60 and older, any sex, with Sarcopenia or Frailty Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized clinical trial aims to evaluate the effectiveness of a structured, multicomponent recreational exercise program (FEXO: Fun Exercise for Older Adults) in improving intrinsic capacity, motivation, and adherence among community-dwelling older adults. Participants aged 60 years and older will be randomly allocated to either the FEXO group or a control group performing the established OTAGO program. The intervention will last 14 weeks, with three weekly sessions. Assessments will be conducted at baseline, post-intervention, and after a 3-month follow-up.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Fun Exercise for Older Adults (FEXO): study protocol for a randomised controlled trial on intrinsic capacity, adherence and motivation.
Azanon-Nogueira P, García-Lucas C, Salvador-Huerta C, Amer-Cuenca JJ, et al · · 2026 · PMID 42203285 · DOI 10.1136/bmjopen-2025-115440

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Cardenal Herrera University trials

Trials by the same sponsor.

NCT07471269 — Online Pain Neuroscience Education For Fear Of Childbirth. · NA · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07499856 — Intradialytic Exercise Program Supported by Audiovisual Media Combined With Mindfulness · NA · enrolling by invitation
NCT07275112 — Cross-cultural an Reliability and Validity Evaluation of TENDINS-A in Spain · completed
NCT07133581 — Design and Validation of FEXO: A Playful Exercise Program for Institutionalized Frail Older Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07133568 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cardenal Herrera University
Last refreshed: 8 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07133568.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing